RISRX | TRZKX | RISRX / TRZKX | |
Total Expense Ratio | 0.94 | 0.00 | - |
Annual Report Gross Expense Ratio | 4.77 | 1.06 | 450% |
Fund Existence | 3 years | 5 years | - |
Gain YTD | 21.210 | 19.921 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.27M | 6.38B | 0% |
Annual Yield % from dividends | 0.82 | 3.23 | 26% |
Returns for 1 year | 17.72 | 15.09 | 117% |
Returns for 3 years | N/A | 42.91 | - |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SFNNX | 13.16 | N/A | N/A |
Schwab Fundamental Intl Equity Index Fd | |||
SMVFX | 11.86 | N/A | N/A |
Virtus Ceredex Mid-Cap Value Equity C | |||
HLHIX | 27.45 | N/A | N/A |
Virtus KAR Health Sciences Inst | |||
RETTX | 30.20 | N/A | N/A |
Russell Inv Global Real Estate Secs M | |||
TRZBX | 216.22 | N/A | N/A |
T. Rowe Price Blue Chip Growth Z |